FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052888691> ?p ?o ?g. }

• W2052888691 endingPage "1884" @default.
• W2052888691 startingPage "1859" @default.
• W2052888691 abstract "Tinidazole, a structural analogue of metrondazole, is an antiprotozoal agent that has been widely used in Europe and developing countries for >2 decades with established efficacy and acceptable tolerability. It was recently approved by the US Food and Drug Administration for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.This article reviews the pharmacologic and pharmacokinetic properties and clinical usefulness of tinidazole.Relevant information was identified through a search of MEDLINE (1966-August 2005), Iowa Drug Information Service (1966-August 2005), and International Pharmaceutical Abstracts (1970-August 2005) using the terms tinidazole, Fasigyn, and nitroimidazole.In vitro, tinidazole exhibits activity against pathogenic protozoa (eg, Tricbomonas vaginalis, Entamoeba bistolytica, Giardia duodenalis), a wide range of clinically significant anaerobic bacteria (eg, Bacteroides fragilis, Clostridium difficile), and the microaerophilic bacterium Helicobacter pylori. In susceptible protozoal and bacterial cells, tinidazole is reduced to cytotoxic intermediates that covalently bind to DNA, causing irreversible damage. In human adults, tinidazole had a bioavailability of 100% and a V(d) of 50.7 L, was minimally bound to plasma protein (12%), had a plasma elimination t((1/2)) of 12.3 hours, and was eliminated primarily by hepatic metabolism (approximately 63%). Dose adjustment does not appear to be necessary on the basis of race, sex, or renal function. No data were found on the disposition of tinidazole in patients with hepatic insufficiency; therefore, use of tinidazole in patients with severe hepatic impairment (Child-Pugh class C) is not recommended. Clinical cure rates in patients with trichomoniasis, giardiasis, amebiasis, and amebic liver abscess were generally >90%. In comparative trials, tinidazole was as effective as metronidazole in the treatment of trichomoniasis and was significantly more effective than metronidazole in the treatment of giardiasis (P < 0.05) and amebiasis (P < 0.05). The most commonly reported (>1%) adverse effects included bitter taste, nausea, abdominal discomfort, anorexia, vomiting, and fatigue. The recommended dosage of tinidazole is a single dose of 2 g for trichomoniasis and giardiasis, and 2 g/d for 3 to 5 days for amebiasis.Tinidazole appears to be a promising agent for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess. Clinical studies are needed to evaluate the use of tinidazole against anaerobic bacteria and H pylori." @default.
• W2052888691 created "2016-06-24" @default.
• W2052888691 creator A5010075376 @default.
• W2052888691 creator A5079628378 @default.
• W2052888691 date "2005-12-01" @default.
• W2052888691 modified "2023-09-25" @default.
• W2052888691 title "Tinidazole: A nitroimidazole antiprotozoal agent" @default.
• W2052888691 cites W119819653 @default.
• W2052888691 cites W1487682906 @default.
• W2052888691 cites W1900222236 @default.
• W2052888691 cites W1970978207 @default.
• W2052888691 cites W1978117246 @default.
• W2052888691 cites W1978277240 @default.
• W2052888691 cites W1982867878 @default.
• W2052888691 cites W1987827439 @default.
• W2052888691 cites W1990715612 @default.
• W2052888691 cites W1990770244 @default.
• W2052888691 cites W1991050218 @default.
• W2052888691 cites W1991699207 @default.
• W2052888691 cites W1994555035 @default.
• W2052888691 cites W2000500375 @default.
• W2052888691 cites W2002580298 @default.
• W2052888691 cites W2007109238 @default.
• W2052888691 cites W2012171112 @default.
• W2052888691 cites W2015698972 @default.
• W2052888691 cites W2016120110 @default.
• W2052888691 cites W2021303229 @default.
• W2052888691 cites W2022821119 @default.
• W2052888691 cites W2028369162 @default.
• W2052888691 cites W2028783789 @default.
• W2052888691 cites W2036259942 @default.
• W2052888691 cites W2036821005 @default.
• W2052888691 cites W2043686966 @default.
• W2052888691 cites W2044585331 @default.
• W2052888691 cites W2052338131 @default.
• W2052888691 cites W2055489819 @default.
• W2052888691 cites W2058774690 @default.
• W2052888691 cites W2058827357 @default.
• W2052888691 cites W2058879348 @default.
• W2052888691 cites W2061938579 @default.
• W2052888691 cites W2069252754 @default.
• W2052888691 cites W2069513725 @default.
• W2052888691 cites W2073203046 @default.
• W2052888691 cites W2073558647 @default.
• W2052888691 cites W2076164288 @default.
• W2052888691 cites W2077350253 @default.
• W2052888691 cites W2078837279 @default.
• W2052888691 cites W2082984819 @default.
• W2052888691 cites W2086129721 @default.
• W2052888691 cites W2086272030 @default.
• W2052888691 cites W2090351739 @default.
• W2052888691 cites W2091675945 @default.
• W2052888691 cites W2100194553 @default.
• W2052888691 cites W2102824635 @default.
• W2052888691 cites W2106683700 @default.
• W2052888691 cites W2109981777 @default.
• W2052888691 cites W2110253587 @default.
• W2052888691 cites W2111350478 @default.
• W2052888691 cites W2124721897 @default.
• W2052888691 cites W2126492194 @default.
• W2052888691 cites W2136841432 @default.
• W2052888691 cites W2152173141 @default.
• W2052888691 cites W2158287049 @default.
• W2052888691 cites W2159238470 @default.
• W2052888691 cites W2163507075 @default.
• W2052888691 cites W2183622001 @default.
• W2052888691 cites W2272874581 @default.
• W2052888691 cites W2313535803 @default.
• W2052888691 cites W2324809871 @default.
• W2052888691 cites W23818722 @default.
• W2052888691 cites W253709144 @default.
• W2052888691 cites W4254107338 @default.
• W2052888691 cites W2137664399 @default.
• W2052888691 cites W2166059779 @default.
• W2052888691 doi "https://doi.org/10.1016/j.clinthera.2005.12.012" @default.
• W2052888691 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16507373" @default.
• W2052888691 hasPublicationYear "2005" @default.
• W2052888691 type Work @default.
• W2052888691 sameAs 2052888691 @default.
• W2052888691 citedByCount "120" @default.
• W2052888691 countsByYear W20528886912012 @default.
• W2052888691 countsByYear W20528886912013 @default.
• W2052888691 countsByYear W20528886912014 @default.
• W2052888691 countsByYear W20528886912015 @default.
• W2052888691 countsByYear W20528886912016 @default.
• W2052888691 countsByYear W20528886912017 @default.
• W2052888691 countsByYear W20528886912018 @default.
• W2052888691 countsByYear W20528886912019 @default.
• W2052888691 countsByYear W20528886912020 @default.
• W2052888691 countsByYear W20528886912021 @default.
• W2052888691 countsByYear W20528886912022 @default.
• W2052888691 countsByYear W20528886912023 @default.
• W2052888691 crossrefType "journal-article" @default.
• W2052888691 hasAuthorship W2052888691A5010075376 @default.
• W2052888691 hasAuthorship W2052888691A5079628378 @default.
• W2052888691 hasConcept C126322002 @default.
• W2052888691 hasConcept C142724271 @default.
• W2052888691 hasConcept C202751555 @default.

• next